Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$96.77

0.23 (0.24%)

13:17
03/13/18
03/13
13:17
03/13/18
13:17

Technical Take: Microsoft move up off lows

The shares were last down over 1.8% to $95.01, off the low of the day set at $94.57. On a retest of the low, next support would be at $93.99. Current resistance is at the $96 area.

  • 13

    Mar

  • 14

    Mar

MSFT Microsoft
$96.77

0.23 (0.24%)

02/15/18
JEFF
02/15/18
UPGRADE
Target $132
JEFF
Buy
Salesforce upgraded to Buy from Hold at Jefferies
Jefferies analyst John DiFucci upgraded Salesforce (CRM) to Buy and raised his price target for the shares to $132 from $97. Recent field checks indicate continued strong enterprise traction as well improved commercial segment momentum, likely due to moderating Microsoft (MSFT) competition, DiFucci tells investors in a research note. The analyst sees "meaningful" billings upside in Q4 and "many engines of growth" to Salesforce achieving its long-term targets. He views the valuation as reasonable at current share levels.
02/20/18
LOOP
02/20/18
UPGRADE
Target $21
LOOP
Buy
HP Enterprise upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Ananda Baruah upgraded HP Enterprise (HPE) to Buy and raised her price target for the shares to $21 from $14.50. The analyst sees "multiple catalysts" over the next 8-12 quarters. She believes HP Enterprise can generate 30c per share in incremental earnings from its NEXT initiative cost savings and an additional 20c from extinguishing its buyback authorization of $5B by fiscal 2020. Further, Baruah thinks the company's Tier 1 Cloud business with Microsoft (MSFT) is no longer declining.
03/09/18
PIPR
03/09/18
NO CHANGE
Target $134
PIPR
Overweight
Proofpoint price target raised to $134 from $123 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for Proofpoint (PFPT) to $134 after hosting investor meetings with CEO Gary Steele. The analyst believes the guidance management provided for Wombat in 2018 is likely conservative. Microsoft (MSFT) seems to be less focused on the security value of its E5 solution, which should result in continued market share gains for Proofpoint, Nowinski tells investors in a research note. The analyst reiterates an Overweight rating on Proofpoint shares.
03/12/18
DBAB
03/12/18
NO CHANGE
Target $120
DBAB
Buy
Microsoft price target raised to $120 from $115 at Deutsche Bank
Deutsche Bank analyst Karl Keirstead raised his price target for Microsoft to $120 after hosting a group of investors in Seattle at the company's headquarters. The tone around the "huge" Office and Server Product segments as well as the emerging Azure business is improving, Keirstead tells investors in a research note. The analyst also sees signs of accelerating overall IT spending growth. He keeps a Buy rating on Microsoft shares.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/18/18
12/18
12:16
12/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOXO

XO Group

$35.00

0.015 (0.04%)

12:12
12/18/18
12/18
12:12
12/18/18
12:12
Hot Stocks
XO Group shareholders approve merger with WeddingWire »

XO Group announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:07
12/18/18
12/18
12:07
12/18/18
12:07
Hot Stocks
DOJ says Germany's IAV GmbH to Pay $35M fine for role in VW emissions fraud »

IAV GmbH, IAV, a German…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$24.00

0.78 (3.36%)

12:05
12/18/18
12/18
12:05
12/18/18
12:05
Options
DSW call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$19.06

-2.36 (-11.02%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Luxfer falls -10.9% »

Luxfer is down -10.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

BPT

BP Prudhoe Bay

$22.75

-2.745 (-10.77%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
BP Prudhoe Bay falls -11.2% »

BP Prudhoe Bay is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$81.94

-11.81 (-12.60%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -12.4% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$16.08

1.7 (11.82%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Britannia Bulk rises 11.7% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$81.37

8.68 (11.94%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 11.9% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$26.90

3.06 (12.84%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Navistar rises 12.8% »

Navistar is up 12.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

11:57
12/18/18
12/18
11:57
12/18/18
11:57
Periodicals
Volkswagen seen gaining edge in German test case, Bloomberg says »

Volkswagen will more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$84.00

-3.45 (-3.95%)

11:55
12/18/18
12/18
11:55
12/18/18
11:55
Options
Twilio put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

11:55
12/18/18
12/18
11:55
12/18/18
11:55
Conference/Events
RBC Capital retail-hardlines analyst to hold a group luncheon »

Retail/Hardlines Analyst…

ADTN

Adtran

$10.92

-0.05 (-0.46%)

11:51
12/18/18
12/18
11:51
12/18/18
11:51
Earnings
Adtran announces CAF II solutions to address rural U.S. areas without broadband »

Adtran announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
12/18/18
12/18
11:50
12/18/18
11:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

FB

Facebook

$143.24

2.93 (2.09%)

11:47
12/18/18
12/18
11:47
12/18/18
11:47
Hot Stocks
Facebook COO Sandberg says needs to step up efforts to curb misinformation »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMT

American Tower

$162.39

1.47 (0.91%)

11:45
12/18/18
12/18
11:45
12/18/18
11:45
Conference/Events
American Tower management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

, ENDP

Endo

$9.45

(0.00%)

11:43
12/18/18
12/18
11:43
12/18/18
11:43
Hot Stocks
Catalyst Pharmaceuticals, Endo sign definitive agreement for vigabatrin tablets »

Catalyst Pharmaceuticals…

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

ENDP

Endo

$9.45

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.39

-0.26 (-1.47%)

11:40
12/18/18
12/18
11:40
12/18/18
11:40
Options
Put buyer in Teva Pharmaceuticals appears to adjust week-old position »

Put buyer in Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
12/18/18
12/18
11:40
12/18/18
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

AMTB

Mercantil Bank

$12.30

(0.00%)

11:39
12/18/18
12/18
11:39
12/18/18
11:39
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

AXGN

AxoGen

$26.39

-1.14 (-4.14%)

11:38
12/18/18
12/18
11:38
12/18/18
11:38
Periodicals
AxoGen mentioned cautiously in a Seeking Alpha article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTB

Mercantil Bank

$12.30

(0.00%)

11:34
12/18/18
12/18
11:34
12/18/18
11:34
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

, INTC

Intel

$48.02

0.93 (1.97%)

11:30
12/18/18
12/18
11:30
12/18/18
11:30
Recommendations
Maxim Integrated, Intel, Inphi, Cisco, Macom analyst commentary  »

Cisco acquisition of…

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

INTC

Intel

$48.02

0.93 (1.97%)

IPHI

Inphi

$33.50

0.96 (2.95%)

CSCO

Cisco

$44.04

-0.17 (-0.38%)

MTSI

Macom

$15.86

0.46 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

  • 10

    Jan

  • 04

    Mar

CBIO

Catalyst Biosciences

$8.93

-0.33 (-3.56%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
Catalyst Biosciences to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.